Literature DB >> 6434086

Accumulation of midazolam after repeated dosage in patients receiving mechanical ventilation in an intensive care unit.

C M Byatt, L D Lewis, S Dawling, G M Cochrane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6434086      PMCID： PMC1442903          DOI： 10.1136/bmj.289.6448.799

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Administration of erythromycin to patients on theophylline.

Authors:  P P Kozak; L H Cummins; S H Gillman
Journal:  J Allergy Clin Immunol       Date:  1977-08       Impact factor: 10.793

2.  Midazolam kinetics.

Authors:  H Allonen; G Ziegler; U Klotz
Journal:  Clin Pharmacol Ther       Date:  1981-11       Impact factor: 6.875

3.  Tissue persistence of gentamicin in man.

Authors:  J J Schentag; W J Jusko; M E Plaut; T J Cumbo; J W Vance; E Abrutyn
Journal:  JAMA       Date:  1977-07-25       Impact factor: 56.272
  3 in total
  22 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids.

Authors:  Maria Korak-Leiter; Rudolf Likar; Michael Oher; Ernst Trampitsch; Gerda Ziervogel; Joseph V Levy; Enno C Freye
Journal:  Intensive Care Med       Date:  2005-02-16       Impact factor: 17.440

3.  Detection of overdosage of sedation in a patient with renal failure by the absence of lower oesophageal motility.

Authors:  M E Sinclair; P M Suter
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

4.  Profound reduction in morphine clearance and liver blood flow in shock.

Authors:  M S Macnab; D J Macrae; E Guy; I S Grant; J Feely
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

5.  The pharmacokinetics of midazolam following orthotopic liver transplantation.

Authors:  M P Shelly; J S Dixon; G R Park
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

6.  Extra-hepatic metabolism of midazolam.

Authors:  G R Park; A R Manara; S Dawling
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

Review 7.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

8.  A pharmacokinetic interaction between roxithromycin and midazolam.

Authors:  J T Backman; K Aranko; J J Himberg; K T Olkkola
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

9.  Midazolam infusion for basal sedation in intensive care: absence of accumulation.

Authors:  S Michalk; C Moncorge; A Fichelle; O Huot; F Servin; R Farinotti; J M Desmonts
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

10.  Pharmacokinetics of antibiotics in critically ill patients.

Authors:  R van Dalen; T B Vree
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.